Tumor-associated carbohydrate antigens of MUC1 - Implication in cancer development.

Cancer Glycosylation MUC1 Mucins TACAs

Journal

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295

Informations de publication

Date de publication:
20 Apr 2024
Historique:
received: 29 01 2024
revised: 12 04 2024
accepted: 17 04 2024
medline: 22 4 2024
pubmed: 22 4 2024
entrez: 21 4 2024
Statut: aheadofprint

Résumé

Glycosylation of cancerous epithelial MUC1 protein is specifically altered in comparison to that which is presented by healthy cells. One of such changes is appearing tumor-associated carbohydrate antigens (TACAs) which are rare in normal tissues and are highly correlated with poor clinical outcomes and cancer progression. This review summarizes and describes the role of Tn, T antigens, their sialylated forms as well as fucosylated Lewis epitopes in different aspects of tumor development, progression, and metastasis. Finally, applications of MUC1 glycan epitopes as potential targets for therapeutic strategy of cancers are notified. One of the novelties of this review is presentation of TACAs as inherently connected with MUC1 mucin.

Identifiants

pubmed: 38643541
pii: S0753-3322(24)00503-1
doi: 10.1016/j.biopha.2024.116619
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

116619

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Iwona Radziejewska (I)

Department of Medical Chemistry, Medical University of Białystok, ul. Mickiewicza 2, Białystok 15-222, Poland. Electronic address: iwona@umb.edu.pl.

Classifications MeSH